Northern Minnesota boy receives pioneering muscular dystrophy treatment

An 8-year-old boy from northern Minnesota has become one of the first Americans to receive a new type of gene therapy for muscular dystrophy. Colton Belluzzo was diagnosed with Duchenne muscular dystrophy (DMD) when he was just 7 months old. This rare disease weakens muscles and often leads to a shortened life expectancy. Colton is known for his lively personality. He enjoys outdoor activities, fishing, and even sharing weather updates on camera. However, his condition had worsened, making it difficult for him to stand. In search of help, his family discovered Dr. Peter Karachunski, who had an innovative treatment plan. In December, doctors injected a virus containing a copy of the dystrophin gene into Colton's body. This gene is important for muscle function and may slow the progression of DMD. Although the idea of injecting a virus into their son was frightening, Colton’s parents understood it was a necessary step. Since the treatment, Colton has shown significant improvement. He can now navigate stairs independently and has more energy to play. His parents are thrilled with his progress and believe that more treatments in clinical trials could further help him in the future. They remain hopeful and encouraged as Colton looks forward to playing baseball soon.